))
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
…
continue reading
1
Renal Cell Carcinoma | Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review
1:02:26
1:02:26
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:02:26
Featuring perspectives from Dr Rana R McKay and Prof Thomas Powles, including the following topics: Introduction (0:00) Management of Metastatic Clear Cell Renal Cell Carcinoma (RCC) — Prof Powles (12:39) Treatment Approaches for Nonmetastatic RCC; Optimal Care of Patients with Non-Clear Cell RCC — Dr McKay (49:27) CME information and select public…
…
continue reading
1
Colorectal Cancer | RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
1:02:37
1:02:37
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:02:37
Featuring perspectives from Dr Scott Kopetz and Dr John Strickler, including the following topics: Introduction (0:00) Recent Therapeutic Advances in Colorectal Cancer (CRC) — Dr Strickler (1:53) New Developments in Targeted Therapy for Metastatic CRC — Dr Kopetz (35:11) CME information and select publications…
…
continue reading
1
Lymphoma | RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
1:00:50
1:00:50
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:50
Featuring perspectives from Dr Joshua Brody, Dr Ian W Flinn and Dr Tycel Phillips, including the following topics: Introduction: CD3 Bispecific Antibodies in the Community Oncology Setting (0:00) Integration of Bispecific Antibody Therapy into the Management of Diffuse Large B-Cell Lymphoma — Dr Phillips (18:13) Current and Future Role of Bispecifi…
…
continue reading
1
Triple-Negative Breast Cancer | What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
1:03:59
1:03:59
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:03:59
Featuring perspectives from Dr Kevin Kalinsky and Dr Heather McArthur, including the following topics: Introduction (0:00) Case: A woman in her mid 80s with a 2.7-cm residual tumor after neoadjuvant pembrolizumab/chemotherapy for localized triple-negative breast cancer (TNBC) — Ranju Gupta, MD (3:31) Question and Comments: Approach to neoadjuvant t…
…
continue reading
1
Multiple Myeloma | Breakfast with the Investigators: New Advances in Multiple Myeloma
1:00:01
1:00:01
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:01
Featuring perspectives from Dr Rafael Fonseca, Dr María-Victoria Mateos and Dr Elizabeth O’Donnell, moderated by Dr O’Donnell, including the following topics: Introduction (0:00) Treatment Approaches for Newly Diagnosed Multiple Myeloma (MM) — Dr Fonseca (2:05) Role of Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies in the Care o…
…
continue reading
1
Lung Cancer | Breakfast with the Investigators: Current and Emerging Role of Antibody-Drug Conjugates in the Treatment of Lung Cancer
59:19
59:19
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
59:19
Featuring perspectives from Dr Rebecca S Heist, Dr Luis Paz-Ares and Dr Jacob Sands, moderated by Dr Sands, including the following topics: Introduction (0:00) Integration of Antibody-Drug Conjugates (ADCs) into the Care of Patients with Non-Small Cell Lung Cancer (NSCLC) and HER2 Alterations — Dr Paz-Ares (1:28) Emerging Role of TROP2-Targeted ADC…
…
continue reading
1
Myelofibrosis | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
1:00:07
1:00:07
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:07
Featuring perspectives from Dr Aaron T Gerds, including the following topics: Introduction: Myelofibrosis (MF) for Oncology “Newbies” (0:00) Biology of MF (5:20) Management of Anemia in MF (20:12) Novel Strategies for MF (29:28) Journal Club (46:12) CME information and select publicationsبقلم Dr. Neil Love
…
continue reading
1
Prostate Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Prostate Cancer
2:04:25
2:04:25
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
2:04:25
Featuring perspectives from Dr Neeraj Agarwal, Dr Emmanuel S Antonarakis, Dr Andrew J Armstrong, Dr Tanya B Dorff and Dr Matthew R Smith, moderated by Dr Armstrong, including the following topics: Introduction (0:00) Optimizing the Management of Nonmetastatic Prostate Cancer — Dr Dorff (3:34) Evidence-Based Selection of Treatment for Metastatic Hor…
…
continue reading
1
Metastatic Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Metastatic Breast Cancer
1:59:33
1:59:33
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:59:33
Featuring perspectives from Dr Aditya Bardia, Dr Harold J Burstein, Prof Giuseppe Curigliano, Dr Sara A Hurvitz, Dr Hope S Rugo and Dr Joyce O’Shaughnessy, moderated by Dr Rugo, including the following topics: Introduction (0:00) Optimizing the Management of HER2-Positive Metastatic Breast Cancer (mBC) — Dr Hurvitz (4:38) Individualized Selection o…
…
continue reading
1
Ovarian and Endometrial Cancer | Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Ovarian and Endometrial Cancer
1:57:16
1:57:16
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:57:16
Featuring perspectives from Dr Floor J Backes, Dr Mansoor Raza Mirza, Dr Ritu Salani, Dr Angeles Alvarez Secord and Dr Brian M Slomovitz, with cases presented by Dr Eric H Lee, Dr Priya Rudolph and Dr Lyndsay J Willmott, moderated by Dr Secord, including the following topics: Up-Front Treatment for Advanced Ovarian Cancer (OC) — Dr Salani Introduct…
…
continue reading
1
Antibody-Drug Conjugates | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Optimal Implementation of Antibody-Drug Conjugates
1:29:14
1:29:14
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:29:14
Featuring perspectives from Ms Jamie Carroll, Ms Kelly EH Goodwin, Dr Erika Hamilton and Dr Hope S Rugo, including the following topics: Introduction (0:00) Overview of Antibody-Drug Conjugates (ADCs); HER2-Targeted ADCs for Breast Cancer — T-DM1, Trastuzumab Deruxtecan (7:22) The Incidence and Management of Interstitial Lung Disease with ADCs (34:…
…
continue reading
1
Hepatobiliary Cancers | Lunch with the Investigators: Hepatobiliary Cancers
1:02:32
1:02:32
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:02:32
Featuring perspectives from Dr Robin K (Katie) Kelley, Dr Edward Kim and Prof Arndt Vogel, and moderated by Dr Kelley, including the following topics: Introduction (0:00) Recent Developments in the Management of Early- and Intermediate-Stage Hepatocellular Carcinoma (HCC) — Dr Kim (1:58) First-Line Therapy for Advanced HCC and Biliary Tract Cancers…
…
continue reading
1
Non-Small Cell Lung Cancer | Second Opinion: Investigators Discuss How They Apply Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer with an EGFR Mutation
1:59:49
1:59:49
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:59:49
Featuring perspectives from Dr Jonathan W Goldman, Dr Corey J Langer, Dr Joel W Neal, Dr Zofia Piotrowska, Dr Joshua K Sabari and Dr Helena Yu, moderated by Dr Yu, including the following topics: Introduction (0:00) Contemporary Care for Patients with Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation — Dr Langer (2:08) Evolving…
…
continue reading
